Latest Content

There are significant, and uneven, knowledge gaps among physicians treating patients with mantle cell lymphoma and chronic lymphocytic leukemia across countries and settings, a survey finds.

Addressing unmet campus mental health needs supports student academic performance while promoting long-term health equity and affordability.

Orbital rhabdomyosarcoma survival held steady despite less-intensive chemo and radiation, according to 25-year data.

AI-driven platform boosts screening capacity 41%, cuts manual review by 75% across Ochsner's 47 hospitals and 370 clinics.

A study shows mobile integrated health was well received by patients and clinicians despite barriers to broader implementation.

How states can partner with free clinics and other local programs to realign incentives for uninsured patients.

The FDA has approved oveporexton (Orzeyful), the first orexin agonist for narcolepsy type 1, based on phase 3 data showing broad symptom improvement.

Lab abnormalities can emerge between visits, and pharmacists may be able to catch uncontrolled hematocrit, adherence issues, or access barriers early.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.